Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-08-23T00:10:42Z No. of bitstreams: 1 CintiaMirelaGuimaraesNobre_DISSERT.pdf: 2892729 bytes, checksum: 15d799d4d877b912519dfec4b25a526b (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-08-23T00:16:57Z (GMT) No. of bitstreams: 1 CintiaMirelaGuimaraesNobre_DISSERT.pdf: 2892729 bytes, checksum: 15d799d4d877b912519dfec4b25a526b (MD5) / Made available in DSpace on 2016-08-23T00:16:57Z (GMT). No. of bitstreams: 1 CintiaMirelaGuimaraesNobre_DISSERT.pdf: 2892729 bytes, checksum: 15d799d4d877b912519dfec4b25a526b (MD5) Previous issue date: 2015-08-05 / A doen?a periodontal (DP) e o diabetes mellitus (DM) apresentam uma associa??o bidirecional, na qual o diabetes favorece o desenvolvimento da DP e esta, quando n?o tratada, pode piorar o controle metab?lico do DM. Logo, a DP deve ser tratada para restabelecer a sa?de dos tecidos periodontais e diminuir as complica??es do diabetes. Portanto, objetiva-se avaliar clinicamente o efeito da terapia periodontal de descontamina??o da boca completa (Full Mouth Scaling and Root Planning - FMSRP) em pacientes diab?ticos tipo II portadores de periodontite cr?nica durante 12 meses. Trinta e um participantes no grupo controle (GC), sem diabetes e com periodontite cr?nica, e 12 no grupo teste (GT) foram avaliados no baseline, aos 03, 06, 09 e 12 meses. Foram analisados os seguintes par?metros cl?nicos periodontais: ?ndice de sangramento a sondagem (ISS), ?ndice de placa vis?vel (IPV), profundidade de sondagem (PS), n?vel cl?nico de inser??o (NCI) e recess?o gengival (RG). Para o GT, tamb?m foram realizados exames laboratoriais para avaliar os par?metros sangu?neos de glicose em jejum e hemoglobina glicada (HbA1c). Os resultados foram analisados de duas formas distintas: uma utilizando todos os s?tios presentes na boca e outra apenas com os s?tios doentes. Foram utilizados o teste de Mann-Whitney, Friedman e Wilcoxon com um n?vel de signific?ncia de 5%. Na an?lise intergrupo de todos os s?tios, percebe-se que n?o houve diferen?a significativa ao longo do tempo em rela??o ? PS, ISS, IPV, NCI e RG (p>0,05). Entretanto, ao avaliar os s?tios doentes, observamos diferen?a significativa somente para o NCI, sendo maior para o GT. A an?lise intragrupo de todos os s?tios mostrou uma redu??o estatisticamente significativa para a PS, IPV e ISS em ambos os grupos. Para os s?tios doentes, a an?lise intragrupo mostrou uma redu??o estatisticamente significativa na PS, ISS e NCI em ambos os grupos. Apesar de haver diminui??o nos valores no ISS nos dois grupos, apenas no GC pode-se perceber uma redu??o estatisticamente significativa. N?o houve altera??o no grupo teste em rela??o ? HbA1c e a glicemia em jejum nos per?odos avaliados. Logo, conclui-se que houve melhoras nos par?metros cl?nicos periodontais ao longo dos 12 meses da pesquisa, por?m sem altera??es nos n?veis glic?micos dos pacientes diab?ticos. Portanto, a terapia periodontal mostrou-se eficiente para os cuidados da sa?de bucal. / There is a bidirectional association between periodontal disease (PD) and diabetes mellitus, in which diabetes favors the development of PD and PD, if left untreated, can worsen the metabolic control of diabetes. Thus, periodontal disease should be treated to restore periodontal health and reduce the complications of diabetes. Therefore, the objective is assess the effect of full mouth periodontal therapy decontamination (Full Mouth Desinfection - FMD) in diabetic type II patients with chronic periodontitis during 12 months. Thirty-one patients in group one (G1) and 12 in group two (G2) were followed at baseline, 03, 06 09 and 12 months. There following clinical parameters were accessed: probing on bleeding (BOP), visible plaque index (PI), probing depth (PD), clinical attachment level (CAL) and gingival recession (GR). For diabetic patients, there were also made laboratory tests to evaluate blood parameters: fasting glucose and glycated hemoglobin. The results had been analyzed in two ways: all sites in the mouth and another with diseased sites. The Mann-Whitney, Friedman and Wilcoxon tests were used with 5% significance. Intergroup analysis of all sites it is clear that there was no significant difference over time concerning PD, BOP, PI, CAL and RG. However, when evaluating the diseased sites, we observed significant difference for CAL and PD, with higher values in G1. The intragroup analysis for all sites showed a statistically significant reduction at PD, PI and BOP in both groups. Intragroup analysis of periodontal affected sites showed a statistically significant reduction in PD, BOP and CAL in both groups. There was also a statistically significant increase in RG values. There was no significant change concerning glycated hemoglobin and fasting glucose in the G1. Therefore, it can be concluded that there were improvements in periodontal parameters over the 12 months of research, but without changes in glycemic levels of diabetic patients. Thus, periodontal therapy proved effective in maintaining oral health.